pmc logo image
The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis
Susan J Cleator, Trevor J Powles, Tim Dexter, Laura Fulford, Alan Mackay, Ian E Smith, Haukur Valgeirsson, Alan Ashworth, Mitch Dowsett
Breast Cancer Res. 2006; 8(3): R32. Published online 2006 June 21. doi: 10.1186/bcr1506
PMCID:
PMC1557729
Abstract Full Text PDF–328K Supplementary Material
 Is Cited by the Following 10 Articles in this Archive:
Systematic Bias in Genomic Classification Due to Contaminating Non-neoplastic Tissue in Breast Tumor Samples
Fathi Elloumi, Zhiyuan Hu, Yan Li, Joel S Parker, Margaret L Gulley, Keith D Amos, Melissa A Troester
BMC Med Genomics. 2011; 4: 54. Published online 2011 June 30. doi: 10.1186/1755-8794-4-54
PMCID:
PMC3151208
Abstract Full Text PDF–941K Supplementary Material
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Res. 2011; 13(3): 212. Published online 2011 June 27. doi: 10.1186/bcr2890
PMCID:
PMC3218943
Abstract Full Text PDF–359K
Integrative computational biology for cancer research
Kristen Fortney, Igor Jurisica
Hum Genet. 2011 October; 130(4): 465–481. Published online 2011 April 22. doi: 10.1007/s00439-011-0983-z
PMCID:
PMC3179275
Abstract Full Text PDF–2.3M Supplementary Material
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box
Caterina Marchiò, Mitch Dowsett, Jorge S Reis-Filho
BMC Med. 2011; 9: 41. Published online 2011 April 19. doi: 10.1186/1741-7015-9-41
PMCID:
PMC3102629
Abstract Full Text PDF–516K
Gene expression deconvolution in clinical samples
Yingdong Zhao, Richard Simon
Genome Med. 2010; 2(12): 93. Published online 2010 December 29. doi: 10.1186/gm214
PMCID:
PMC3025435
Abstract Full Text PDF–230K
In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome
Simen Myhre, Hayat Mohammed, Trine Tramm, Jan Alsner, Greg Finak, Morag Park, Jens Overgaard, Anne-Lise Børresen-Dale, Arnoldo Frigessi, Therese Sørlie
PLoS One. 2010; 5(11): e14002. Published online 2010 November 19. doi: 10.1371/journal.pone.0014002
PMCID:
PMC2988804
Abstract Full Text PDF–2.8M Supplementary Material
Statistical expression deconvolution from mixed tissue samples
Jennifer Clarke, Pearl Seo, Bertrand Clarke
Bioinformatics. 2010 April 15; 26(8): 1043–1049. Published online 2010 March 4. doi: 10.1093/bioinformatics/btq097
PMCID:
PMC2853690
Abstract Full Text PDF–4.1M
PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer
G Munkácsy, R Abdul-Ghani, Z Mihály, B Tegze, O Tchernitsa, P Surowiak, R Schäfer, B Györffy
Br J Cancer. 2010 January 19; 102(2): 361–368. Published online 2009 December 15. doi: 10.1038/sj.bjc.6605478
PMCID:
PMC2816652
Abstract Full Text PDF–720K
Evaluation of the current knowledge limitations in breast cancer research: a gap analysis
Alastair Thompson, Keith Brennan, Angela Cox, Julia Gee, Diana Harcourt, Adrian Harris, Michelle Harvie, Ingunn Holen, Anthony Howell, Robert Nicholson, Michael Steel, Charles Streuli, Breast Cancer Campaign Gap Analysis Meeting (2 November 2006, London, UK)
Breast Cancer Res. 2008; 10(2): R26. Published online 2008 March 27. doi: 10.1186/bcr1983
PMCID:
PMC2397525
Abstract Full Text PDF–390K
Molecular response to aromatase inhibitor treatment in primary breast cancer
Alan Mackay, Ander Urruticoechea, J Michael Dixon, Tim Dexter, Kerry Fenwick, Alan Ashworth, Suzanne Drury, Alexey Larionov, Oliver Young, Sharon White, William R Miller, Dean B Evans, Mitch Dowsett
Breast Cancer Res. 2007; 9(3): R37. Published online 2007 June 7. doi: 10.1186/bcr1732
PMCID:
PMC1929101
Abstract Full Text PDF–2.0M Supplementary Material
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk